Cellectar Biosciences Return on Net Operating Assets Insights

Cellectar Biosciences, Inc. (CLRB)

3.98 +0.21 (+5.57%) USD | NASDAQ | Dec 08, 16:00

3.965 -0.02 (-0.38%) After-Hours: 20:00

View Return on Net Operating Assets for CLRB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Imunon, Inc.	Upgrade
PDS Biotechnology Corp.	Upgrade
PAVmed, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	Upgrade